Tokyo, Japan

Ryogo Yui



 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ryogo Yui: Innovator in Immunosuppressive and Anti-Tumor Agents

Introduction

Ryogo Yui is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of immunosuppressive and anti-tumor agents. With a total of 2 patents to his name, Yui's work is paving the way for advancements in medical treatments.

Latest Patents

Yui's latest patents focus on innovative methods for treating immune diseases. One of his notable inventions is an immunosuppressive agent and anti-tumor agent that comprises a heterocyclic compound as an active ingredient. This novel method involves administering a therapeutically effective amount of a heterocyclic compound, represented by a specific general formula, to mammals suffering from immune diseases. Additionally, he has disclosed a new heterocyclic compound, also represented by a general formula, which can be used in pharmaceutical applications.

Career Highlights

Ryogo Yui is associated with Zenyaku Kogyo Kabushiki Kaisha, a company known for its focus on pharmaceutical innovations. His work at this organization has allowed him to explore and develop groundbreaking treatments that address critical health issues.

Collaborations

Yui collaborates with esteemed colleagues, including Kazuhiko Haruta and Shinichi Yaguchi. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Ryogo Yui's contributions to immunosuppressive and anti-tumor agents highlight his role as a key innovator in the pharmaceutical industry. His patents reflect a commitment to improving health outcomes through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…